We support clinical research using iPSCs by simultaneously providing multiple clinical-grade iPSC lines. I Peace’s compact and fully-automated iPSC manufacturing system enables mass production of clinical grade iPSCs from multiple donors in a single room. Increasing the available number of clinical-grade iPSC lines allows our customers to take multiple factors, including differentiation propensity, into account and to select the most appropriate iPSC line for their own clinical research. I Peace’s production facility has a clean room that meets the standards set by the Japanese Ministry of Health, Labor and Welfare, and has been licensed by the Kinki Health and Welfare Bureau to manufacture specific cell products. Skilled technicians with the qualifications of a Clinical Cell Culture Specialist manufacture products strictly following SOPs (Standard Operating Procedures). In addition, all processes of cell production and quality inspection are documented to provide guaranteed traceability. The culture solution used for the production of iPSCs is GMP-grade and does not contain any animal-derived components. By introducing reprogramming genes in a manner that does not damage genomic DNA, we can provide high-quality iPSCs without any residual reprogramming factors.